Companies / Bolt Biotherapeutics, Inc. / Activity
Activity — Bolt Biotherapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Quinn William P. CEO | Buy | Common Stock | $576 | +125 +5.71% | 2,313 0.12% of shares | low |
| Dec 5, 2025 | Nemec Sarah Executive | Buy | Common Stock | $576 | +125 +9.69% | 1,415 0.07% of shares | low |
| Jun 10, 2026 | Onetto Nicole Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,000 0.26% of shares | low |
| Jun 10, 2026 | Laporte Kathleen Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,000 0.26% of shares | low |
| Jan 28, 2026 | Quinn William P. CEO | Grant | Employee Stock Option (Right to Buy) | — | +20K | 20,000 1.04% of shares | low |
| Jan 28, 2026 | Yonehiro Grant Executive | Grant | Employee Stock Option (Right to Buy) | — | +10K | 10,000 0.52% of shares | low |
| Jan 28, 2026 | Nemec Sarah Executive | Grant | Employee Stock Option (Right to Buy) | — | +8K | 8,000 0.42% of shares | low |